Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications. Chang PH, Huang SF, Chang PS, Yu Y, et al. J Dermatol 2021 Aug 30. doi: 10.1111/1346-8138.16116.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chang PH, Huang SF, Chang PS, Yu Y, et al. Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications. J Dermatol 2021 Aug 30. doi: 10.1111/1346-8138.16116.
PMID: 34462967